CLINICAL_TRIALS
trial_result
· 2014-08-18
Clinical Trial Update: The Effect of Boceprevir in Russian Participants Diagnosed With Chronic Hepatitis C Genotype 1 (P08160) [Phase 3]
Summary
Phase 3 trial update assessing boceprevir in Russian participants with chronic hepatitis C genotype 1; study completed with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Chronic Hepatitis C Genotype 1 | Phase 3 | Status: COMPLETED | Results posted: 2014-08-18